EMPAGLIFLOXIN – A SWEET SURPRISE!

diabetes-complications.jpg

A lot of attention has been focused on a new class of drug for diabetics called sodium glucose co-transporter inhibitors (SGLT-2i). It alters the way glucose and sodium are treated in the kidneys and for the diabetic can lead to increased loss of sugar and water through urine. A large relatively recent study called EMPA-REG looked at this medication for diabetics. To everyone’s surprise, the study started to show improved outcomes that were just not expected. There appeared to be a decrease in overall mortality, a reduction in heart failure and even a reduction in progression to renal failure. The drug leads to decreased blood sugar levels hence improving glucose control but also lowers total body water which appears very important in reduction of risk in heart failure and possibly activation of the sympathetic nervous system. This is particularly the case for the type of heart failure which we see in diabetics which we call preserved left ventricular function failure or shortness of breath with a heart that appears to work well. SGLT-2i is showing promise in terms of reducing hospitalisation and improving mortality in diabetics. There is now more and more research looking into this class of drug. The drug most representative of the class is called Empaglifloxin and I am sure this will be used more and more on a routine basis for diabetics to help manage their sugar levels and #hearthealth. #diabetes #heartattack

Join The Healthy Heart Network

Comments are closed

Use of this Web site constitutes your acceptance of our Terms & Conditions / Privacy Policy and trademarks and brands are the property of their respective owners.

Understandably, Dr Bishop is unable to provide individual patient advice over the internet due to the complexity [Read More]

This site is not a part of the Facebook website or Facebook, Inc. Additionally, this site is not endorsed by Facebook in any way. Facebook is a trademark of Facebook, Inc.
Authorised Licensee: Dr Warrick Bishop Cardiology Imaging and Miscellaneous Support Pty Ltd  ABN: 83 614 478 358

Connect with Dr Warrick Bishop



Copyright © 2024 whatsmyheartattackrisk.com - All rights reserved.